Clinical trials show modest but sustained improvements in motor symptoms and suggest benefits in cognition, mood, and apathy
Endotext/NCBI, 2024)
The Bottom Line Relumins Nutrition Drinks succeed because they combine science-backed ingredients with a delicious, easy-to-drink format that people actually stick with
Disclosures Alan Kaplan has conflicts in being either a member of an advisory board or speakers bureau of the following companies: Astra Zeneca, Behring, Boerhinger Ingelheim, Cipla, Covis, Eiasi, GSK, Merck Frosst, Novartis, Novo Nordisk, Pfizer, Sanofi Genzyme, Teva, Trudel, Valeo
"Das Antifebrin, ein neues Fiebermittel" [Antifebrin, a new antipyretic]